4-(tert-Butoxy)-6-chloropyrimidin-2-amine

Catalog No.: 
ACZHLA425
CAS No.: 
1209664-59-4
Molecular Formula: 
C8H12ClN3O
Molecular Weight: 
201.66
4-(tert-Butoxy)-6-chloropyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$428.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(tert-Butoxy)-6-chloropyrimidin-2-amine
IUPAC Name4-(tert-butoxy)-6-chloropyrimidin-2-amine
Molecular FormulaC8H12ClN3O
Molecular Weight201.66
SMILESNC1=NC(Cl)=CC(OC(C)(C)C)=N1
InChI KeyZVSQUMMTCDJNSF-UHFFFAOYSA-N
Synonym2-Pyrimidinamine, 4-chloro-6-(1,1-dimethylethoxy)-
CAS No.1209664-59-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZHLA425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACZHLA425 route product structure diagram
    ACZHLA4251209664-59-4
Inquiry

2. ACZHLA425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. ACNUES385 route compound structure diagram
    ACNUES38556-05-3
  4. Then
  5. ACZHLA425 route product structure diagram
    ACZHLA4251209664-59-4
Inquiry

3. ACZHLA425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. ACNUES385 route compound structure diagram
    ACNUES38556-05-3
  4. Then
  5. ACZHLA425 route product structure diagram
    ACZHLA4251209664-59-4
Inquiry

Comments (0)